ArticleClinical cancer research : an official journal of the American Association for Cancer Research2024

Safety Profile and Adverse Event Management for Futibatinib, An Irreversible FGFR1-4 Inhibitor: Pooled Safety Analysis of 469 Patients.

Funda Meric-Bernstam et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.